comparemela.com
  1. Home
  2. Live Updates
  3. Program Mulago - Breaking News

Program Mulago News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Completion of isoniazid–rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness–implementation randomized trial

In this interim analysis, Adithya Cattamanchi and colleagues report their findings on 3HP patient acceptance and completion in a routine HIV care context.

South africaUnited statesSan franciscoUniversitatsklinikum heidelbergClaudiam denkingerUniversity of californiaTrial steering committeeProgram mulagoCalifornia health care foundationUganda national tuberculosisGlobal health labsMakerere university jointEthics committeeSan francisco human research protection programBlood instituteEverwell health solutions

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.